Skip to content

Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial.

Larissa G Duncan, Judith Tedlie Moskowitz, Torsten B Neilands, Samantha E Dilworth, Frederick M Hecht, Mallory O. Johnson

Journal of Pain and Symptom Management September 17, 2011 DOI: 10.1016/j.jpainsymman.2011.04.007 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 76
Population People living with HIV who were actively taking antiretroviral therapy and reported distress from ART-related side effects
Intervention Mindfulness-Based Stress Reduction (MBSR)
Duration Three-month and six-month follow-up
Topics Meditation
Keywords Humans Hiv infections Anti-retroviral agents Treatment outcome Prevalence Stress, psychological Comorbidity Middle aged Waiting lists California Female
Key findings Compared with a wait-list control, MBSR reduced the frequency of symptoms attributable to antiretroviral therapy at three months (mean difference 0.33) and six months (mean difference 0.38), and reduced distress associated with those symptoms at three months (mean difference 0.47). The authors conclude that MBSR is a promising approach for reducing HIV treatment-related side effects.

Abstract

Context: Advances in antiretroviral therapy (ART) for HIV offer life-extending benefit; however, the side effects associated with ART use negatively impact quality of life and medication adherence among people living with HIV.

Objectives: This study tested the efficacy of Mindfulness-Based Stress Reduction (MBSR) for reducing ART symptoms and bother/distress related to ART side effects. Secondary aims were to test the impact of MBSR on medication adherence and psychological functioning.

Methods: Seventy-six people living with HIV who were actively taking ART and reported distress from ART-related side effects were randomly assigned to an MBSR program or a wait-list control (WLC) standard care condition. We measured side effects, ART adherence, perceived stress, depression, positive and negative affect, and mindfulness at three time points: baseline, three-month follow-up, and six-month follow-up. Side effects and related distress were assessed separately from other symptoms.

Results: Compared with a WLC, participants in the MBSR condition experienced a reduction in the frequency of symptoms attributable to ARTs at three months post-intervention (mean difference=0.33; 95% confidence interval [CI]=0.01, 0.66; t(132)=2.04, P=0.044) and six months post-intervention (mean difference=0.38; 95% CI=0.05, 0.71; t(132)=2.27, P=0.025). MBSR participants also experienced a reduction in distress associated with those symptoms at three months post-intervention (mean difference=0.47; 95% CI=0.003, 0.94; t(132)=1.99, P=0.048) compared with the WLC condition.

Conclusion: MBSR is a promising approach for reducing HIV treatment-related side effects.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics